Skip to main content
. 2017 Jan;360(1):14–22. doi: 10.1124/jpet.116.236620

TABLE 1.

SODD expression in BE, low-grade dysplasia, high-grade dysplasia, and esophageal adenocarcinoma

Negative Mild Moderate Strong
Barrett's cells (N = 19) 1 (5.3%) 2 (10.5%) 14 (73.7%) 2 (10.5%)
Low-grade dysplasia (N = 6) 0 0 2 (33.3%) 4 (66.7%)*
High-grade dysplasia (N = 16) 0 0 3 (18.8%) 13 (81.2%)*
EA (N = 7) 0 0 2 (28.6%) 5 (71.4%)*
*

P < 0.01, compared with Barrett’s cells.